---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-163526"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T04:43:55.199976+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Savara updates corporate presentation; no material new disclosures

## Summary
- Updated corporate presentation posted on IR page and furnished as Exhibit 99.1.
- Presentation covers Savara's rare respiratory disease pipeline, no specific financial/operational updates provided.
- No changes to guidance, pipeline status, or financial outlook disclosed in the filing.
- Savara undertakes no obligation to update the presentation except through normal channels.

## SEC filing metadata
- accession: 0001193125-23-163526
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312523163526/0001193125-23-163526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312523163526/d518536d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-163526
- JSON: https://secwatch.observer/filing/0001193125-23-163526.json
- Plain text: https://secwatch.observer/filing/0001193125-23-163526.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.